title: Current results with triple therapy for heart transplantation.
authors.affiliation: Department of Surgery, Cardiology, and Pathology, Washington University School of Medicine, St Louis, MO.
authors.forename: R M
authors.initials: RM
authors.lastname: Bolman
authors.forename: M T
authors.initials: MT
authors.lastname: Olivari
authors.forename: J
authors.initials: J
authors.lastname: Saffitz
authors.forename: R
authors.initials: R
authors.lastname: Sibley
authors.forename: J
authors.initials: J
authors.lastname: Spadaro
authors.forename: C
authors.initials: C
authors.lastname: Cance
authors.forename: B
authors.initials: B
authors.lastname: Elick
mesh_terms: D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone